European Medicines Agency

• Prognostic factors in mid-life for predicting subsequent frailty: systematic literature review

  Grants or research support, 15 Sept 2026

Sources: pubmed.ncbi.nlm.nih.gov

• Pharmacologic Treatments for Female Menopausal Vasomotor Symptoms: A Systematic Review and Meta-analysis for the American College of Physicians

  Annals of internal medicine, 6 Oct 2026

• Plasma hippuric acid as a marker of frailty influenced by dietary fruit and vegetable consumption: longitudinal analysis in Italian cohorts of older adults

  npj aging, 10 Apr 2026

• Differential performance of plasma p ‐tau217 in detecting intermediate vs high Alzheimer's disease neuropathologic change

  AAIC 2025 abstract, 26 Dec 2025

• Rates of Progression to Tau‐PET Positivity in Preclinical Alzheimer’s Disease

  AAIC 2025 abstract, 23 Dec 2025

• Telomere-targeted medicine: Bridging molecular mechanisms and clinical applications in age-related diseases

  Life sciences, 14 Aug 2025

• Should the European Medicines Agency consider ageing a disease?

  Bioethics, 2 Jan 2024